Results 101 to 110 of about 406,273 (304)
Plasma tau complements CSF tau and P‐tau in the diagnosis of Alzheimer's disease
AbstractIntroductionPlasma tau may be an accessible biomarker for Alzheimer's disease (AD), but the correlation between plasma and cerebrospinal fluid (CSF) tau and the value of combining plasma tau with CSF tau and phospho‐tau (P‐tau) are still unclear.MethodsPlasma‐tau, CSF‐tau, and P‐tau were measured in 97 subjects, including elderly cognitively ...
Fossati, S +10 more
openaire +4 more sources
ABSTRACT Background Blood‐based biomarkers are increasingly used to identify Alzheimer's disease (AD) pathology and may play an important role in early disease screening and participant selection for clinical trials. However, their performance across stages of cognitive impairment remains unclear. This study examined whether plasma biomarkers differ in
Maryam Abdolmaleki +7 more
wiley +1 more source
Objective To assess the validity of the Patient‐Reported Outcomes Measurement Information System (PROMIS) Pediatric measures in patients with chronic nonbacterial osteomyelitis (CNO). Methods Within the longitudinal patient registry of CNO, English‐speaking patients aged 8 years and older self‐reported PROMIS Pediatric measures of fatigue, pain ...
Mary M. Eckert +43 more
wiley +1 more source
The normalised-difference vegetative index (NDVI) seasonal dynamics of 15 types of vegetation communities in dry 2010 and in 2016 with a favourable weather conditions was studied in the Pre-Urals Steppe site where the Programme on establishing a semi ...
Nikolay I. Fedorov +4 more
doaj +1 more source
Summary of the Tau 2016 Workshop
The main topics discussed at the Tau 2016 Workshop are briefly summarized. A large number of reports were given on low-energy QCD studies, on the hadronic g−2 contribution, and on neutrino Physics.
Alberto Lusiani, LUSIANI, Alberto
core +1 more source
Polyserine-tau interactions modulate tau fibrillization
Abstract Tau aggregates are the defining feature of multiple neurodegenerative diseases and contribute to the pathology of disease. However, the molecules affecting tau aggregation in cells are unclear. We previously determined that polyserine-rich domain containing proteins enrich in tau aggregates, assemble into ...
James Pratt +3 more
openaire +2 more sources
Objective This study aimed to determine whether gout flare resolution is associated with physical activity and sleep. These findings were intended to inform the future development of a definition for flare resolution. Methods Data from 81 participants with gout who experienced at least one flare during a six‐month prospective observational study were ...
Sarah Stewart +12 more
wiley +1 more source
The HFAG-Tau group has computed the world averages of the tau lepton properties using the experimental results available in early 2012. The tau lepton branching fractions, mass and lifetime are used to test lepton universality for charged weak currents ...
Hayasaka, Kiyoshi +5 more
core +1 more source
Objective Patient‐reported outcome measures (PROMs) are central to assessing symptom burden and treatment response in Osteoarthritis (OA) but are often embedded in unstructured clinical notes. We evaluated whether prompt‐engineered large language models (LLMs) could accurately extract or infer pain scores on a 0‐10 scale from routine OA clinical ...
Jainesh Doshi +7 more
wiley +1 more source
jkbrynildsen/tau-spread: Network modeling of tau pathology spread
<p>Code to reproduce all network analyses in Lubben et al. "LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology spread". Scripts are modified versions of those found in https://github.com/ejcorn/tau-spread.&
jkbrynildsen, Eli Cornblath
core +2 more sources

